IndiaOne Finance - Company Dashboard

Governance Classic Home

Medicamen Biotech LtdPharmaceuticalsINE646B01010Consolidated₹330.25-17.35 (-4.99%)Jun-26

Valuation

Market Cap₹447.91 Cr

TTM PE44.57x

Forward PE42.34x

PEG17.90

Book Value₹203.17

P/B1.63x

TTM EPS₹7.41

Fwd EPS₹7.80

TTM Revenue₹202.63 Cr

TTM PAT₹10.05 Cr

TTM EBITDA₹19.31 Cr

TTM EBIT₹12.10 Cr

Last Qtr PAT₹1.85 Cr

Last Qtr EBITDA₹4.33 Cr

Last Qtr EBIT₹2.54 Cr

Profitability

ROE3.65%

ROCE4.82%

TTM NPM4.96%

TTM EBITDA %9.53%

Curr OPM3.79%

Last OPM7.13%

Curr NPM—

Last NPM—

Curr EPS₹1.36

Last EPS₹3.28

Balance sheet

Equity₹13.56 Cr

Reserve₹261.99 Cr

Total Debt₹47.78 Cr

D/E0.17x

Interest %44.86%

Curr Interest₹0.83 Cr

Price / range

Close₹330.25

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-4.99%

1W+2.09%

1M+46.16%

3M+47.27%

6M+21.75%

1Y-1.23%

2Y-28.58%

3Y-51.46%

5Y-45.97%

Diwali-13.07%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	43.85+14.0%	54.68	43.49	42.23	38.45	178.85
Other Income	0.86	1.73	0.54	0.37	0.47	3.10
Total Income	44.71+14.9%	56.41	44.03	42.60	38.92	181.95
Interest	0.64	0.60	0.78	0.84	0.56	2.78
Expenditure	-41.46-12.8%	-52.88	-40.94	-39.83	-36.75	-170.40
PBDT	0	0	0	0	0	0
EBITDA	4.77+18.4%	4.13	5.08	5.05	4.03	18.29
Depreciation	-1.74	-1.73	-1.75	-1.81	-1.77	-7.06
EBIT	3.03+34.1%	2.40	3.33	3.24	2.26	11.23
PBT	3.26+50.2%	3.53	3.08	2.77	2.17	11.55
Tax	-0.73	-0.56	-0.49	-0.56	-0.53	-2.14
Equity	13.56	13.56	0	0	13.56	13.56
OPM	7.29	6.26	7.08	6.56	5.58	6.35
Net Profit	2.53+54.3%	2.97	2.59	2.21	1.64	9.41
NPM	5.66	5.27	5.96	5.22	4.21	5.17
EPS	1.86+53.7%	2.19	1.91	1.63	1.21	6.94

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	178.85+18.1%	151.46-12.1%	172.39+25.0%	137.88+19.4%	115.45+4.8%	110.15
Other Income	3.10	6.23	2.30	2.46	1.72	0.75
Total Income	181.95+15.4%	157.69-9.7%	174.69+24.5%	140.35+19.8%	117.17+5.7%	110.90
Expenditure	-170.40-17.6%	-144.90+8.2%	-157.80-28.3%	-123.01-24.2%	-99.06-5.2%	-94.15
Interest	-2.78	-3.05	-4.38	-2.92	-1.40	-1.06
PBDT	0	0	0	0	0	0
EBITDA	18.29+10.4%	16.56-36.3%	25.98+7.6%	24.14+2.5%	23.56+20.3%	19.58
Depreciation	-7.06	-6.95	-7.01	-6.35	-5.77	-2.52
EBIT	11.23+16.9%	9.61-49.3%	18.97+6.6%	17.79+0.0%	17.79+4.3%	17.06
PBT	11.55-9.6%	12.78-24.3%	16.89-2.5%	17.33-4.3%	18.10+8.1%	16.75
Tax	-2.14	-3.32	-3.59	-2.33	-3.20	-4.27
Equity	13.56	12.71	0	0	0	0
OPM (%)	6.35	8.11	10.00	12.00	15.00	15.00
Net Profit	9.41-0.5%	9.46-28.9%	13.30-11.3%	15+0.6%	14.91+19.4%	12.49
NPM (%)	5.17	6.00	8.00	11.00	13.00	11.00
EPS (Rs)	6.94-6.7%	7.44-29.1%	10.50-12.8%	12.04-1.3%	12.20+19.4%	10.22
CEPS	6.94	7.44	10.50	12.04	12.20	10.22

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	47.90+11.3%	60.65	46.91	47.17	43.04	197.77
Other Income	0.86	1.74	0.54	0.37	0.47	3.11
Total Income	48.76+12.0%	62.38	47.44	47.54	43.52	200.88
Interest	0.83	0.38	0.97	0.99	1.15	3.50
Expenditure	-46.19-11.6%	-57.32	-45.33	-44.86	-41.38	-188.90
PBDT	0	0	0	0	0	0
EBITDA	4.33-6.1%	5.44	4.38	5.16	4.61	19.59
Depreciation	-1.79	-1.73	-1.83	-1.86	-1.80	-7.22
EBIT	2.54-9.6%	3.71	2.55	3.30	2.81	12.37
PBT	2.57+20.7%	5.06	2.11	2.68	2.13	11.98
Tax	-0.73	-0.61	-0.48	-0.57	-0.53	-2.19
Equity	13.56	13.56	0	0	13.56	13.56
OPM	5.27	8.11	4.45	5.64	4.89	5.97
Net Profit	1.85+15.6%	4.45	1.64	2.11	1.60	9.80
NPM	3.79	7.13	3.45	4.45	3.68	4.88
EPS	1.36+15.3%	3.28	1.21	1.56	1.18	7.22

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	197.77+21.7%	162.55-9.3%	179.31+27.3%	140.87+22.0%	115.45+2.4%	112.72
Other Income	3.11	6.24	2.33	2.46	1.72	0.75
Total Income	200.88+19.0%	168.79-7.1%	181.63+26.7%	143.33+22.3%	117.17+3.3%	113.47
Expenditure	-188.90-18.9%	-158.91+5.7%	-168.56-33.5%	-126.29-27.5%	-99.07-2.0%	-97.08
Interest	-3.50	-3.16	-4.40	-2.92	-1.40	-1.06
PBDT	0	0	0	0	0	0
EBITDA	19.59+41.2%	13.87-37.6%	22.24-6.8%	23.87+1.4%	23.55+22.5%	19.22
Depreciation	-7.22	-7.07	-7.09	-6.37	-5.77	-2.52
EBIT	12.37+81.9%	6.80-55.1%	15.15-13.4%	17.50-1.6%	17.78+6.5%	16.70
PBT	11.98+21.3%	9.88-24.5%	13.08-23.3%	17.05-5.7%	18.09+10.4%	16.39
Tax	-2.19	-3.32	-3.58	-2.32	-3.20	-4.27
Equity	13.56	12.71	0	0	0	0
OPM (%)	5.97	5.85	7.20	11.89	15.44	14.45
Net Profit	9.80+49.4%	6.56-30.9%	9.49-35.6%	14.73-1.1%	14.90+22.8%	12.13
NPM (%)	4.88	3.88	5.23	10.28	12.71	10.69
EPS (Rs)	7.22+39.9%	5.16-31.2%	7.50-36.5%	11.82-3.0%	12.19+22.8%	9.93
CEPS	7.22	5.16	7.50	11.82	12.19	9.93

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1	19 Sep 2025
2024	Final Dividend	1	19 Sep 2024
2024	Final Dividend	1	18 Sep 2024
2023	Final Dividend	1	20 Sep 2023
2022	Final Dividend	1	19 Sep 2022
2021	Final Dividend	1	16 Sep 2021
2020	Final Dividend	0.5	17 Sep 2020
2019	Final Dividend	1	17 Sep 2019
2018	Interim Dividend	1	08 Aug 2017
2010	Final Dividend	0.75	21 Sep 2010

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split